Vatanen T, Kostic AD, d’Hennezel E, et al. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell. 2016;165(4):842-53. doi:10.1016/j.cell.2016.04.007
Florez JC. Found in Translation: A Type 1 Diabetes Genetic Risk Score Applied to Clinical Diagnosis. Diabetes Care. 2016;39(3):330-2. doi:10.2337/dci15-0029
Semenkovich CF, Danska J, Darsow T, et al. American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome. Diabetes. 2015;64(12):3967-77. doi:10.2337/db15-0597
Hu X, Deutsch AJ, Lenz TL, et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat Genet. 2015;47(8):898-905. doi:10.1038/ng.3353
Onengut-Gumuscu S, Chen WM, Burren O, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47(4):381-6. doi:10.1038/ng.3245
Kostic AD, Gevers D, Siljander H, et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 2015;17(2):260-73. doi:10.1016/j.chom.2015.01.001
Liao J, Jijon HB, Kim IR, et al. An image-based genetic assay identifies genes in T1D susceptibility loci controlling cellular antiviral immunity in mouse. PLoS One. 2014;9(9):e108777. doi:10.1371/journal.pone.0108777
Hu X, Kim H, Raj T, et al. Regulation of gene expression in autoimmune disease loci and the genetic basis of proliferation in CD4+ effector memory T cells. PLoS Genet. 2014;10(6):e1004404. doi:10.1371/journal.pgen.1004404
Zhang Y, Welzig CM, Picard KL, et al. Glycogen synthase kinase-3β inhibition ameliorates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice. Diabetes. 2014;63(6):2097-113. doi:10.2337/db12-1459
Han B, Kang EY, Raychaudhuri S, de Bakker PIW, Eskin E. Fast pairwise IBD association testing in genome-wide association studies. Bioinformatics. 2014;30(2):206-13. doi:10.1093/bioinformatics/btt609